Andrea Párniczky

ORCID: 0000-0003-3466-4780
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease Diagnosis and Treatment
  • Cystic Fibrosis Research Advances
  • Gastrointestinal disorders and treatments
  • Appendicitis Diagnosis and Management
  • Pediatric Hepatobiliary Diseases and Treatments
  • COVID-19 Clinical Research Studies
  • Diabetes and associated disorders
  • Neonatal Respiratory Health Research
  • Gallbladder and Bile Duct Disorders
  • Childhood Cancer Survivors' Quality of Life
  • Neuroendocrine Tumor Research Advances
  • Eosinophilic Esophagitis
  • Inflammatory Bowel Disease
  • Gastroesophageal reflux and treatments
  • Healthcare cost, quality, practices
  • Regulation of Appetite and Obesity
  • Sepsis Diagnosis and Treatment
  • Muscle and Compartmental Disorders
  • Pregnancy and Medication Impact
  • Intestinal Malrotation and Obstruction Disorders
  • Dermatological and COVID-19 studies
  • Nutritional Studies and Diet
  • Tracheal and airway disorders

University of Pecs
2016-2025

Semmelweis University
2017-2025

Heim Pál Gyermekkórház
2016-2025

University of Szeged
2015-2024

University of California, Los Angeles
2023

Research Network (United States)
2023

National Institutes of Health
2023

National Research, Development and Innovation Office
2023

Cystic Fibrosis Trust
2023

Creative Commons
2023

Objective The aim of this study was to analyse the clinical characteristics acute pancreatitis (AP) in a prospectively collected, large, multicentre cohort and validate major recommendations IAP/APA evidence-based guidelines for management AP. Design Eighty-six different parameters were collected using an electronic research form designed by Hungarian Pancreatic Study Group. Patients 600 adult patients diagnosed with AP enrolled from 17 centres over two-year period 1 January 2013. Main...

10.1371/journal.pone.0165309 article EN cc-by PLoS ONE 2016-10-31

The overall objective of these guidelines is to provide evidence‐based recommendations for the diagnosis and management immunoglobulin G4 (IgG4)‐related digestive disease in adults children. IgG4‐related can be diagnosed only with a comprehensive work‐up that includes histology, organ morphology at imaging, serology, search other involvement, response glucocorticoid treatment. Indications treatment are symptomatic patients obstructive jaundice, abdominal pain, posterior pancreatic...

10.1177/2050640620934911 article EN other-oa United European Gastroenterology Journal 2020-06-18

Hypertriglyceridemia is the third most common cause of acute pancreatitis (AP). It has been shown that hypertriglyceridemia aggravates severity and related complications AP; however, detailed analyses large cohorts are contradictory. Our aim was to investigate dose-dependent effect on AP. AP patients over 18 years old who underwent triglyceride measurement within initial three days were included into our cohort analysis from a prospective international, multicenter registry operated by...

10.1016/j.pan.2020.03.018 article EN cc-by Pancreatology 2020-04-10
Andrea Párniczky Tamás Lantos Eszter Tóth Zsolt Szakács Szilárd Gódi and 95 more Roland Hágendorn Dóra Illés Balázs Koncz Katalin Márta Alexandra Mikó Dóra Mosztbacher Balázs Csaba Németh Dániel Pécsi Anikó Szabó Ákos Szücs Péter Varjú Andrea Szentesi Erika Darvasi Bálint Erőss Ferenc Izbéki László Gajdán Adrienn Halász Áron Vincze Imre Szabó Gabriella Pár Judit Bajor Patrícia Sarlós József Czimmer József Hamvas Tamás Takács Zoltán Szepes László Czakó Márta Varga János Novák Barnabás Bod Attila Szepes János Sümegi Mária Papp Csaba Góg Imola Török Wei Huang Qing Xia Ping Xue Weiqin Li Weiwei Chen N. V. Shirinskaya В. Л. Полуэктов Anna V. Shirinskaya Péter Hegyi M Bátovský Juan A. Rodríguez-Oballe Isabel Miguel Salas Javier López J. Enrique Domínguez‐Muñoz Xavier Molero Elizabeth Pando María Lourdes Ruiz-Rebollo Beatriz Burgueño-Gómez Yu‐Ting Chang Ming-Chu Chang Ajay Sud Danielle Moore Robert Sutton Amir Gougol Georgios I. Papachristou Y. M. Susak Illia Olehovych Tiuliukin António Gomes Maria Jesus Oliveira David Aparício Marcel Tanțău Floreta Kurti Mila Kovacheva-Slavova Stephanie-Susanne Stecher Julia Mayerle Goran Poropat Kshaunish Das Marco V. Marino Gabriele Capurso Ewa Małecka‐Panas Hubert Zatorski Anita Gąsiorowska Natalia Fabisiak Piotr Ceranowicz Beata Kuśnierz‐Cabala Joana Rita Carvalho Samuel Fernandes Jae Hyuck Chang Eun Kwang Choi Jimin Han Sara Bertilsson Hanaz Jumaa Gabriel Sandblom Sabite Kaçar Minas Baltatzis Aliaksandr Varabei Vizhynis Yeshy S. Chooklin A. Kozachenko Nikolay Veligotsky

10.1016/j.pan.2019.04.003 article EN Pancreatology 2019-04-19

The in-hospital survival of patients suffering from acute pancreatitis (AP) is 95% to 98%. However, there growing evidence that discharged after AP may be at risk serious morbidity and mortality. Here, we aimed investigate the risk, causes, predictors most severe consequence post-AP period: mortality.A total 2613 well-characterized 25 centers were included followed by Hungarian Pancreatic Study Group between 2012 2021. A general a hospital-based population was used as control group.After an...

10.1053/j.gastro.2023.05.028 article EN cc-by Gastroenterology 2023-05-27

The incidence of acute pancreatitis (AP) and the prevalence metabolic syndrome (MetS) are growing worldwide. Several studies have confirmed that obesity (OB), hyperlipidemia (HL), or diabetes mellitus (DM) can increase severity, mortality, complications in AP. However, there is no comprehensive information on independent joint effect MetS components outcome Our aims were (1) to understand whether an AP (2) examine their combinations.From 2012 2017, 1435 cases from 28 centers included...

10.3389/fphys.2019.01202 article EN cc-by Frontiers in Physiology 2019-09-20

Chronic pancreatitis (CP) is a complex inflammatory disease with remarkably impaired quality of life and permanent damage the pancreas. This paper part international consensus guidelines on CP presents factors elevating risk for CP.An working group 20 experts from major pancreas societies (IAP, APA, JPS, EPC) evaluated 14 statements generated evidence four questions deemed to be most clinically relevant in CP. The Grading Recommendations Assessment, Development, Evaluation (GRADE) approach...

10.1016/j.pan.2020.03.014 article EN cc-by Pancreatology 2020-04-08

Introduction: Our meta-analysis indicated that aging influences the outcomes of acute pancreatitis (AP), however, a potential role for comorbidities was implicated, as well. Here we aimed to determine how age and modify in AP cohort-analysis Hungarian cases. Materials methods: Data patients diagnosed with by revised Atlanta criteria were extracted from Registry Pancreatic Patients. Outcomes interest mortality, severity, length hospitalization, local, systemic complications AP. Comorbidities...

10.3389/fphys.2018.01776 article EN cc-by Frontiers in Physiology 2019-04-02

Abstract The incidence and medical costs of acute pancreatitis (AP) are on the rise, severe cases still have a 30% mortality rate. We aimed to evaluate hypoalbuminemia as risk factor prognostic value human serum albumin in AP. Data from 2461 patients were extracted international, prospective, multicentre AP registry operated by Hungarian Pancreatic Study Group. with measurement first 48 h (n = 1149) anytime during hospitalization 1272) analysed. Multivariate binary logistic regression...

10.1038/s41598-021-03449-8 article EN cc-by Scientific Reports 2021-12-17

Abstract Chronic pancreatitis (CP) is an end-stage disease with no specific therapy; therefore, early diagnosis of crucial importance. In this study, data from 1315 and 318 patients were analysed acute (AP) CP registries, respectively. The population the AP registry was divided into (n = 983), recurrent (RAP, n 270) 62) groups. prevalence in combination AP, RAP2, RAP3, RAP4 RAP5 + 0%, 1%, 16%, 50% 47%, respectively, suggesting that three or more episodes a strong risk factor for CP....

10.1038/s41598-020-80532-6 article EN cc-by Scientific Reports 2021-01-14

Abstract Introduction Non‐alcoholic fatty liver disease (NAFLD) is a proven risk factor for acute pancreatitis (AP). However, NAFLD has recently been redefined as metabolic‐associated (MAFLD). In this post hoc analysis, we quantified the effect of MAFLD on outcomes AP. Methods We identified our patients from multicentric, prospective International Acute Pancreatitis Registry Hungarian Pancreatic Study Group. Next, compared AP with and without individual components regarding in‐hospital...

10.1002/ueg2.12389 article EN cc-by-nc-nd United European Gastroenterology Journal 2023-04-16
Coming Soon ...